Clinical trial
Treating Obstructive Sleep Apnea Using Targeted Hypoglossal Neurostimulation
NCT04950894 is registered in ClinicalTrials.gov with LivaNova as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Treating Obstructive Sleep Apnea Using Targeted Hypoglossal Neurostimulation
- Lead sponsor
- LivaNova
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 24, 2022
- Completion date
- April 23, 2025
- Enrollment
- 107 (actual)
- Sites
- 19
Conditions
As the registry lists them; a condition with its own page is linked.
apnea, apnea+hypopnea, apnea, obstructive, apnea, obstructive sleep, hypopnea, sleep, obstructive sleep apnea, osa